Literature DB >> 25575079

Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.

Marli Silva1, Laurence Daheron2, Hannah Hurley3, Kim Bure4, Richard Barker3, Andrew J Carr5, David Williams6, Hae-Won Kim7, Anna French1, Pete J Coffey8, Justin J Cooper-White9, Brock Reeve2, Mahendra Rao10, Evan Y Snyder11, Kelvin S Ng12, Benjamin E Mead12, James A Smith13, Jeffrey M Karp12, David A Brindley14, Ivan Wall15.   

Abstract

Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare in the 21(st) century. However, successful commercialization will require standardized manufacturing platforms. Here we highlight the need to define standardized practices for iPSC generation and processing and discuss current challenges to the robust manufacture of iPSC products.
Copyright © 2015 Elsevier Inc. All rights reserved.

Mesh:

Year:  2015        PMID: 25575079     DOI: 10.1016/j.stem.2014.12.013

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  18 in total

1.  Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.

Authors:  Ester Perales-Clemente; Alexandra N Cook; Jared M Evans; Samantha Roellinger; Frank Secreto; Valentina Emmanuele; Devin Oglesbee; Vamsi K Mootha; Michio Hirano; Eric A Schon; Andre Terzic; Timothy J Nelson
Journal:  EMBO J       Date:  2016-07-19       Impact factor: 11.598

Review 2.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

3.  Essential design considerations for the resazurin reduction assay to noninvasively quantify cell expansion within perfused extracellular matrix scaffolds.

Authors:  Joseph S Uzarski; Michael D DiVito; Jason A Wertheim; William M Miller
Journal:  Biomaterials       Date:  2017-02-16       Impact factor: 12.479

Review 4.  Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.

Authors:  Katrina Albert; Jonna Niskanen; Sara Kälvälä; Šárka Lehtonen
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 5.  Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.

Authors:  Shuo Sun; ZhiQing Li; Patrick Glencer; BinCui Cai; XiaoMin Zhang; Jin Yang; XiaoRong Li
Journal:  Stem Cell Res Ther       Date:  2017-06-06       Impact factor: 6.832

6.  A basis for comparison: sensitive authentication of stem cell derived RPE using physiological responses of intact RPE monolayers.

Authors:  Kiyoharu J Miyagishima; Qin Wan; Sheldon S Miller; Kapil Bharti
Journal:  Stem Cell Transl Investig       Date:  2017-01-24

Review 7.  Setting Up a Haplobank: Issues and Solutions.

Authors:  Jacqueline Barry; Johan Hyllner; Glyn Stacey; Craig J Taylor; Marc Turner
Journal:  Curr Stem Cell Rep       Date:  2015

Review 8.  Chemicals as the Sole Transformers of Cell Fate.

Authors:  Behnam Ebrahimi
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

Review 9.  The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside.

Authors:  Nina Xie; Beisha Tang
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

Review 10.  Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review.

Authors:  Neeraj Malhotra
Journal:  Int J Stem Cells       Date:  2016-11-30       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.